MPO and granulomatosis with polyangiitis: A previous nationwide survey of the Japanese population showed that CY was used by 62.3 % of MPA and 96.3 % of GPA patients [11], and a recent study of Japanese patients with MPO-ANCA-associated vasculitis (JMAAV) also reported that 58.3 % of the patients were treated with CY [16].